VVX

6-(1H-Indol-4-yl)-4-(5-{[4-(1-methylethyl)-1-piperazinyl]methyl}-1,3-oxazol-2-yl)-1H-indazole


Toggle HydrogenToggle Labels

Chemical Component Summary

Name6-(1H-Indol-4-yl)-4-(5-{[4-(1-methylethyl)-1-piperazinyl]methyl}-1,3-oxazol-2-yl)-1H-indazole
Identifiers2-[6-(1H-indol-4-yl)-1H-indazol-4-yl]-5-[(4-propan-2-ylpiperazin-1-yl)methyl]-1,3-oxazole
FormulaC26 H28 N6 O
Molecular Weight440.54
TypeNON-POLYMER
Isomeric SMILESCC(C)N1CCN(CC1)Cc2cnc(o2)c3cc(cc4c3cn[nH]4)c5cccc6c5cc[nH]6
InChIInChI=1S/C26H28N6O/c1-17(2)32-10-8-31(9-11-32)16-19-14-28-26(33-19)22-12-18(13-25-23(22)15-29-30-25)20-4-3-5-24-21(20)6-7-27-24/h3-7,12-15,17,27H,8-11,16H2,1-2H3,(H,29,30)
InChIKeyMCIDWGZGWVSZMK-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count61
Chiral Atom Count0
Bond Count66
Aromatic Bond Count25

Drug Info: DrugBank

DrugBank IDDB16253 
NameNemiralisib
Groups investigational
DescriptionNemiralisib is under investigation in clinical trial NCT03345407 (Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)).
SynonymsNemiralisib
Categories
  • Enzyme Inhibitors
  • Heterocyclic Compounds, Fused-Ring
  • Protein Kinase Inhibitors
  • Pyrazoles
CAS number1254036-71-9

Related Resource References

Resource NameReference
Pharos CHEMBL2216859
PubChem 49784002
ChEMBL CHEMBL2216859